Merck & Co., Inc. - 8-K Filing

Merck reports Q3 2026 total sales of $18.1 billion, driven by KEYTRUDA and WINREVAIR growth. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR · October 29, 2026, 10:44 UTC

Tickers: $MRK

Read the full article at SEC EDGAR

Part of the story COGNIZANT TECHNOLOGY SOLUTIONS CORP - 8-K Filing (28 articles)

More Regulatory news

LiveOne, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:45 UTC
Solana Co - 10-Q Filing SEC EDGAR · November 12, 2026, 13:42 UTC
Solana Co - 8-K Filing SEC EDGAR · November 12, 2026, 13:41 UTC
DeFi Development Corp. - 8-K Filing SEC EDGAR · November 12, 2026, 13:41 UTC
Stablecoin Development Corp - 8-K Filing SEC EDGAR · November 12, 2026, 13:40 UTC
BCP Investment Corp - 8-K Filing SEC EDGAR · November 12, 2026, 13:36 UTC
OneWater Marine Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:37 UTC
Moleculin Biotech, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:37 UTC
Investcorp Credit Management BDC, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:37 UTC
Presurance Holdings, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:35 UTC